ACCEL Lite: ACC.22 Late Breaker: ADAPT-TAVR Trial - Edoxaban Versus DAPT For Valve Thrombosis And Cerebral TE After TAVR
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research - Een podcast door American College of Cardiology - Dinsdagen
Categorieën:
What is clinical problem with regard to leaflet thrombosis after TAVR, and what are the main findings of the ADAPT-TAVR trial? In this interview, Duk-Woo Park, MD and Sun Moon Kim MD, with Zaid I. Almarzooq MBBCh, discuss Late Breaker: Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial.
